ArticleFrontiers in medicine2026
A deep learning framework for automated fracture detection and localization in radiographic images using convolutional neural networks.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fracture detecting and localizing in radiographic images is essential to enhance the effectiveness of the diagnosis of trauma and allow the image to be interpreted. Despite the potential potential of the deep learning in musculoskeletal imaging, the quality of classification results and the stability of localization are significant issues. Purpose: The purpose of the work is to design and test a deep learning system that fractures radiographic images and localizes them with the use of convolutional neural networks and object detection on the basis of YOLOv8. Methods: A retrospective secondary data analysis was done based on publicly available, de-identified radiographic data. In fracture classification, three transfer-learning backbones were analyzed: ResNet18, MobileNetV3-Small, and EfficientNet-B0, which were trained on repeated stratified cross-validation with early stopping. The evaluation of model performance was with area under receiver operating characteristic curve (AUROC), average precision (AP), Brier score, accuracy, precision, recall, and specificity and F1-score. The temperature scaling was used to perform probability calibration and the nested threshold optimization to compare the performance at various operating points. To localise fractures, Precision, recall, mAP, 0.5, and mAP, 0.5:0.95 were used to compare and train YOLOv8n, YOLOv8s and YOLOv8m detectors on both validation and test sets. Results: MobileNetV3-Small was the top-performing backbone in terms of overall performance, though the classification discrimination was generally low. Calibration analysis was used to show that probability distribution and reliability properties changed with the scaling of temperature and threshold optimization revealed significant differences in sensitivity, precision, specificity, and F1-score with different decision cutoffs. According to the localization experiment, YOLOv8 showed variability in the performance of the detector variants, with the largest test-set mAPs at 0.5 and the largest variation in classes across anatomical fracture types. These results show that the element of localization in the framework was better and more regular compared to the element of classification in the current experimental setup. Conclusion: The presented framework offers a combined method of fracture classification, calibration of probability, threshold analysis and radiographic localization. Although the classification aspect demonstrated poor discriminative accuracy, the localization outcomes using the YOLOv8 were relatively better in this scenario, which justifies the usefulness of detector-based fracture localization in this context. Clinical translation will be subject to further external validation, prospective assessment, and comparison of experts and readers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.